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Summary 
Previous studies from our laboratory demonstrated an inverse relationship between the expression 
level of inducible nitric oxide synthase (iNOS) and the metastatic potential of murine K-1735 
melanoma cells. The purpose of this study was to provide direct evidence that the expression 
of iNOS suppresses metastatic potential of melanoma cells. Highly metastatic K-1735 clone 4 
cells (C4.P), which express low levels ofiNOS, were transfected with a functional iNOS (C4.L8), 
inactive-mutated iNOS (C4.$2), or neomycin-resistance  (C4.Neo)  genes in medium containing 
3 mM NG-methyl-r-arginine  (NMA).  Positive  transfectants  were identified by Southern and 
Northern blot analyses and homogeneous staining with a specific anti-iNOS monoclonal antibody. 
Semiconfluent cultures of C4.P (parental),  C4.Neo.3 (control transfection), C4.$2.3 (inactive 
iNOS), and C4.L8.5 (functional iNOS) were harvested, and viable cells were injected intravenously 
into syngeneic C3H/HeN mice and aUogeneic BALB/c nude mice. C4.P, C4.Neo.3, and C4.$2.3 
cells were highly metastatic whereas C4.L8.5  cells were not  metastatic.  Experiments with 
[125I]IdUrd-labeled tumor cells demonstrated that the initial arrest in the lung microvasculature 
did not differ among the lines, but that C4.L8.5 cells died by 48-72 h after injection. Enhanced 
survival of all K-1735 C4 cells (including C4.L8.5) was found in mice given twice daily injections 
of 20 mg NMA. The C4.L8.5 cells produced slow growing subcutaneous tumors in nude mice, 
whereas the other three lines produced fast growing tumors. In vitro studies confirmed that 
in the absence of NMA the expression of iNOS in C4.L8.5 cells induced apoptosis. Collectively, 
these data demonstrate that the expression of recombinant iNOS in melanoma cells is associated 
with apoptosis,  suppression of tumorigenicity, and abrogation of metastasis. 
C 
ancer  metastasis  is  produced by metastatic cells that 
preexist within a parental neoplasm (1, 2). During he- 
matogenous metastasis, tumor cells are subjected to such ex- 
treme selection pressures that the majority of tumor cells en- 
tering the circulation rapidly die regardless of their metastatic 
potential (2-5). Tumor cell features, such as deformibility (6), 
aggregation (7), and cell surface adhesion molecules (7, 8) 
and host factors,  such as blood turbulence (6, 9), platelets 
(10,  11), T  cells (12), NK cells (13, 14), and macrophages 
(15), all influence the survival of blood-borne tumor emboli. 
Furthermore, passage of tumor cells through capillaries leads 
to cell lysis by sheer forces (6) and by nitric oxide (NO) 1 
produced by cytokine-activated endothelial cells (16, 17). 
1 Abbreviations used in this paper: iNOS, inducible nitric oxide synthase; 
MTT, dimethylthiazole dephenyl tetrazolium bromide; NMA, NG-methyl  - 
t-arginine; NO, nitric oxide; NOS,  nitric oxide synthase. 
NO  is  derived from the terminal guanido-nitrogen of 
r-arginine (18, 19), which is catalyzed by constitutive nitric 
oxide synthases  (NOS)  or inducible nitric oxide synthase 
(iNOS)  (18-27).  NO  produces multiple effects  that  can 
influence the outcome of metastasis. Specifically, NO regu- 
lates vasodilatation (23, 24) and platelet aggregation (25, 26), 
which affect tumor cell arrest in capillaries (1, 16, 17). NO 
is also a major cytotoxic mediator secreted by activated mac- 
rophages (18-24) and endothelial cells (17) shown to be respon- 
sible for the destruction of tumor cells passing through cap- 
illary  beds.  Moreover,  we  have  recently shown  that  the 
production of endogenous NO is associated with apoptosis 
of tumorigenic cells (27). Taken together, these results sug- 
gest the possibility that production of endogenous NO may 
be detrimental to  tumor cell  survival  and production of 
metastasis. 
Previous studies from Fidler's laboratory have shown that 
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troduced into the circulation,  whereas many metastatic cells 
survive (3, 4). Subsequent studies concluded that nonmetastatic 
cells exhibited high levels ofiNOS activity and NO, whereas 
metastatic cells did not, thus demonstrating an inverse corre- 
lation between production of endogenous NO and the ability 
of K-1735 cells to survive in syngeneic mice to produce lung 
metastases  (28). 
The purpose of this  study was  to provide evidence of a 
causal relation between enhanced iNOS activity in tumor cells 
and decreased metastatic potential. Q. W. Xie et al. have re- 
cently reported  the cloning  and  characterization of iNOS 
cDNAs from mouse macrophages (29) that encoded two iso- 
forms of iNOS.  The enzymaticaUy active piNOS-L8 has a 
longer coding region and the other, enzymatically inactive 
piNOS-S2 has a shorter coding region differing at the COOH 
terminus (30). The inactivity of piNOS-S2 has been attrib- 
uted to its inability to bind NADPH (30). In this study, we 
transfected these iNOS genes into highly metastatic iNOS- 
deficient K-1735 C4 melanoma cells. Transfection with cDNA 
encoding-active iNOS induces apoptosis,  suppresses tumor 
growth,  and abrogates production  of metastasis. 
Materials and Methods 
Reagents.  Eagle's MEM, HBSS, PBS, and fetal bovine serum 
(FBS) were purchased from M. A. Bioproducts (Walkersville, MD). 
[3H]dThd (sp act, 1 mCi/ml) was purchased from ICN Biomed- 
icals, Inc. (Costa Mesa, CA). [125I]IdUrd (sp act, 1 mCi/ml) was 
purchased from New England Nuclear Corp. (Boston, MA). N G- 
methyl-t-arginine (NMA) was purchased from Sigma Chemical Co. 
(St. Louis, MO). All reagents used in tissue culture were free of 
endotoxin as determined by Limulus amebocyte lysate assay (senti- 
tivity limit, 0.125 ng/ml) purchased from Associates of Cape Cod 
(Woods Hole, MA). 
K-1735 Line and Culture Conditions.  The original K-1735 mela- 
noma, induced in a C3H/HeN mouse by exposure to UV light 
followed by painting with croton oil, was a gift of Dr. Margaret 
L. Kripke (The University of Texas M. D. Anderson Cancer Center; 
31). The parental tumor was cloned in vitro by a double dilution 
method. Of the large number of clones  thus isolated,  we chose 
clone 4 (C4), a highly metastatic line that produces melanotic lung 
metastases in syngeneic mice (32). Cell lines were used at low pas- 
sage numbers (passages 6-10) since the original cloning procedure 
or isolation from metastases. Cultures were maintained for no longer 
than 6 wk after recovery from frozen stocks. 
Tumor cell lines were maintained in tissue culture in Eagle's MEM 
supplemented with 5% FBS, sodium pyruvate, nonessential amino 
acids, t-glutamine, and twofold vitamin solution (Flow Laborato- 
ries, Rockville, MD). Cell cultures were maintained on plastic and 
incubated in 5%  CO2-95%  air at 37~  Cultures were free of 
Mycoptasma and the following murine viruses: reovirus type 3, pneu- 
monia virus,  K  virus,  Theiler's encephalitis  virus,  Sendal virus, 
minute virus, mouse adenovirus,  mouse hepatitis virus,  lympho- 
cytic choriomeningitis virus, ectromelia virus, and lactate dehydro- 
genase  virus (assayed by M. A. Bioproducts). 
To prepare tumor ceils for inoculation, ceils in exponential growth 
phase were harvested by a brief exposure to 0.25% trypsin-0.02% 
EDTA solution (wt/vol). The flask was tapped sharply to dislodge 
the cells, supplemented medium added, and the cell suspension 
pipetted again to produce a single-cell suspension.  The cells were 
washed and resuspended  in Ca  2+- and Mg2§  HBSS to  the 
desired cell concentration. Cell viability was determined by trypan 
blue exclusion, and only single-cell suspensions of >90% viability 
were used. 
Tronsfection  Procedures  and Selection  of Clones.  K-1735 C4 parental 
cells  (C4.P)  were  plated  into  100-ram  dishes  at  a  density  of 
1&/dish.  The  monolayers  (60%  confluence) were washed  and 
refed 12-18 h later in L-arginine-free medium containing 3 mM 
NMA (MEM-NMA) to increase transfection effaciency.  The K-1735 
C4.P cells were cotransfected with pcDNAI plasmids  containing 
the Ne0 resistance  gene (peDNAI/Neo) (Invitrogen, San Diego, 
CA), L8 (enzymatically active iNOS, piNOS-L8), or $2 (enzymat- 
ically inactive iNOS, piNOS-S2) genes (29, 30, 33). For each trans- 
fection, 0.8 ml of serum-flee and t-arginine-free MEM-NMA was 
mixed with  0.2  ml diluted lipofectin solution  (GIBCO  BRL, 
Gaithersburg,  MD)  containing  2  /xg  pcDNAI/Neo,  or  2  /xg 
pcDNAI/Neo plus 40/~g piNOS-S2, or 2/zg pcDNAI/Neo plus 
40/~g piNOS-L8. The K-1735 C4 celt monolayers were washed 
with MEM-NMA, and 1 ml of a transfection mixture was evenly 
added to the monolayers. The cultures were placed in a 37~  incu- 
bator for 24 h and then washed and fed with MEM-NMA con- 
taining 500/~g/ml G418 (GIBCO BILL). The r-arginine-ffee MEM- 
NMA/G418 medium was replaced every 3 d until individual resis- 
tant colonies were isolated and established in culture as individual 
lines. All lines were maintained in L-arginine-ffee MEM-NMA/ 
G418 and frozen after one to three in vitro passages. For identification 
of iNOS gene positive cells, 1@ cells from each ctonat line were 
plated into 38-ram 2 wells of 96-well plates and incubated in MEM- 
NMA. After 4-6 h, the adherent cells were washed with medium 
containing 5 mM L-arginine  and then incubated in MEM with 
t-arginine (and without NMA). Culture supernatants were col- 
lected for nitrite analysis as described  below. 
Immunohistochemistry  Using Specific  Anti-iNOS Antibody.  Tumor 
cells were plated on glass coverslips, and 10-12 h later,  the cells 
were fixed by immersing the coverslips in ice-cold acetone for 10 
min. The coverslips were then briefly rinsed in PBS. The endoge- 
nous peroxidase was inactivated by incubating the cells with 3% 
hydrogen peroxide diluted in methanol for 12 rain, followed by 
a rinse with PBS. To minimize nonspecific adsorption of the anti- 
bodies to the coverslips, the samples were incubated with a blocking 
buffer containing 1% BSA and 1% normal goat serum in PBS for 
10-20 min, and then mouse anti-iNOS mAb (Transduction Labora- 
tories, Lexington, KY) diluted in the same blocking buffer (4/xg/ml) 
or preimmune IgG was added. The coverslips were incubated over- 
night at 4~  and then washed three times in PBS and incubated 
with blocking buffer solution for 5-10 rain, followed by a 30- 
60-min incubation with peroxidase-conjugated secondary antibodies 
(rabbit anti-mouse IgG [H+L] antibody, peroxidase conjugated; 
Boehringer Mannheim, Indianapolis, IN) diluted 1:250 in blocking 
buffer. The samples were then washed and incubated for 10 min 
with 3,3-diaminobenzidine, rinsed with distilled  water, counter- 
stained  for 10 s with aqueous hematoxylin, washed three times 
with PBS and once with water, and studied under microscopy. 
In Vitro Cytolysis  Assay.  Cells in their exponential growth phase 
were  incubated  for  18  h  in  medium  containing  0.1  #Ci/ml 
[3H]dThd. The cells were washed twice with MEM containing 
5 mM L-arginine and harvested by trypsinization, and 1.5-2.0  x 
106 viable cells were seeded in triplicate into 30-mm multiple cul- 
ture dishes  for 4-6  h.  After removal of nonadherent cells, the 
monolayers were incubated in MEM alone or MEM-NMA.  The 
dishes were placed in a 37~  incubator, and cultures were termi- 
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monolayers washed three times with PBS (containing Ca  2+  and 
Mg2+).  The adherent cells were lysed by 0.1 N  NaOH, and the 
radioactivity was monitored in a beta counter.  The cytotoxicity 
was  calculated  according  to  the  formula:  cytotoxicity  (%)  = 
(.4 -B)/A  x  100 where A is the counts per minute of plated cells 
and B is the counts per minute of adherent surviving cells. 
In Vitro Cytostasis Assay.  1(-1735 cells were plated at the den- 
sity of 104 cells per 38-ram  2 well of 96-well plates in medium con- 
taining MEM-NMA  (control)  or MEM  (test).  After 72  h,  cell 
number was determined by the dimetbylthiazole dephenyl tetrazo- 
lium bromide (MTT, Sigma Chemical Co.) assay. After incubation 
for 2 h in medium containing MTT at 0.42 mg/mL, the medium 
was removed, and the cells were lysed in dimethyl sulfoxide.  The 
conversion of MTT to formazan by metabolically viable cells (34) 
was monitored by a 96-well microtiter plate reader at 570 nm (Dy- 
natech, Inc., Chantilly, VA). Percent cytostasis was calculated by 
the formula: cytostasis  (%)  --  [1  -  (A/B)]  x  100, where A  is 
the absorbance of test cells incubated in medium or NMA and B 
is the absorbance of the control cells incubated in medium. 
Nitrite Analysis.  Nitrite concentration in culture supernatants 
was determined by a microplate assay described by Ding et al. (35). 
Briefly,  50-#1 samples were harvested from conditioned medium 
and allowed to react with an equal volume of Griess reagent (1% 
sulfanih~de-0.1% naphthylethylene diamine dihydrochloride-2.5% 
H3PO4) at room temperature for 10 min. The absorbance at 540 
nm was monitored with a microplate reader.  Nitrite concentra- 
tions were determined by using sodium nitrite as a standard. 
Extraction and Measurement of iNOS Activity.  Tumor cells were 
scraped into a lysis buffer (20 mM Tris/HC1,  pH 7.5,  137 mM 
NaC1, 1 mM PMSF, 10 #g/ml aprotinin, 10 #g/ml leupeptin, and 
5 #g/ml pepstatin A) at a density of 4  x  107 cells/ml and dis- 
rupted by sonication (Soniprep 150; Curtin Matheson Scientific, 
Inc., Houston,  TX; 60%  output,  two times for 10 s each);  the 
suspension was centrifuged at 18,000 g for 30 min at 4~  NOS 
activity in the supematants was measured as t-arginine~and  NADPH- 
dependent generation of NO2-/NO3-,  the stable oxidation prod- 
ucts  of NO.  NOS  activity was expressed as nmol/mg protein. 
Sodium nitrite was used to plot the standard curves (36-38). The 
protein concentration of iNOS preparations was measured by the 
Bradford method using a miniprotein assay kit (Bio-Rad Laborato- 
ties,  Richmond,  CA) with BSA as a standard  (39). 
Southern Blot Analysis.  DNA was extracted from different cell 
lines. Equal amounts of DNA (20/~g) were digested with HindlII 
and XbaI for 18 h at 37~  After precipitation, DNA was sepa- 
rated on a 0.8% agarose gel. Equal loading was checked by ethidium 
bromide staining. DNA in the gel was depurinized by incubation 
in 0.25 N HC1 for 10 min and denatured in 0.5 N  NaOH/1.5 M 
NaC1 for 60 min. After neutralizing in 1 M "Iris, pH 7.0/1.5 M 
NaC1 for 60 min, DNA was transferred to a Nytran membrane 
(Schleicher  & Schuell,  Inc., Keene, NH) in 20x  SSC. After being 
baked at 80~  for 2 h and prehybridized for 4 h, the filter mem- 
branes were hybridized for 16-18 h to a 32p-labeled iNOS cDNA 
probe (see below). Hybridization reactions were performed in 25 
mM KPO4, pH 7.5, 5x  SSC, 5￿  Denhardt's solution, 50 #g/ml 
salmon sperm DNA, 50% formamide, and 10% dextran sulfate. 
The filters were washed in 2x  SSC/0.5%  SDS twice for 30 rain 
at room temperature and 0.1x  SSC/0.1%  SDS twice for 60 min 
at 65~  The filter membrane was exposed for 4-24 h to Kodak 
X-Omat XAK Film (Eastman Kodak, Rochester,  NY). 
iNOS mRNA Transcript  Analysis.  Cellular mRNA was prepared 
by using FastTrack kit (Invitrogen). The mKNA samples (2 #g) 
were separated electrophoretically in 1.0% agarose gels containing 
MOPS buffer with 0.66 M  formaldehyde. The RNA was trans- 
ferred to a GeneScreen membrane (New England Nuclear) in 20 x 
SSC and UV-cross-linked with a UV Stratalinker 1800 (Stratagene, 
La Jolla, CA). The XbaI- and HindlII-digested 4.0-kb cDNA in- 
sert from piNOS-L8 was used as the probe for iNOS (29) and la- 
beled  with  [32p]CTP  using  a  random  labeling  kit  (Boehringer 
Mannheim). The membranes were prehybridized for 4 h and then 
hybridized for 16-18 h in a buffer containing 2% Genius blocking 
reagent,  5￿  SSC, 0.1%  sodium sarkosyl, 7% SDS,  and 50 mM 
NaPO4,  pH 6.8,  at 42~  Equal loading of RNA  samples was 
monitored  by  hybridization  with  a  routine  glyceraldehyde-3- 
phosphate dehydrogenase (GAPDH) cDNA probe. Filters were ex- 
posed for 6-48 h  to Kodak X-Omat XAR film. 
DNA Fragmentation Assay.  Quantitative DNA damage was as- 
sayed according to previously published procedures with minor 
modifications  (27,  40-43).  Briefly,  1.5-2.0  x  106  [3H]dThd- 
labeled cells were seeded in triplicate into 30-mm dishes  in 2 ml 
of MEM or MEM-NMA.  Cells were harvested at different times 
and centrifuged at 2,500 rpm for 10 rain. The supernatant fluids 
(A) were collected and DNA was precipitated by 5% TCA. The 
cell pellets were suspended in a lysis buffer consisting of 8 mM 
EDTA, 20 mM Tris (pH 8.0),  and 0.2% (vol/vol) Triton X-100. 
After 20 min at room temperature, the lysates were centrifuged 
at 13,000 g  for 5 min. The low molecular weight DNA in the 
postnuclear  supernatant  (B) was collected and intact chromatin 
DNA (C) was dissolved  in TE buffer consisting of 10 mM Tris 
(pH 7.5) and I mM EDTA. Radioactivity in the three preparations 
(A, B, and C) was determined in a beta counter. DNA fragmenta- 
tion expressed as a percentage was calculated by the formula [(A 
+  B)/(A+B+C)]  ￿  100. 
Qualitative Analysis of lntemucleosomal DNA Fragmentation.  Inter- 
nucleosomal DNA fragmentation was determined qualitatively by 
agarose gel electrophoresis (27, 40-43). Briefly, the low molecular 
weight DNA in the postnuclear supernatant (B) and intact chro- 
matin DNA in the pellet (C) were treated with proteinase K and 
precipitated  with ethanol at - 70~  overnight after extraction with 
phenol and chloroform. The DNA was then pelleted and dissolved 
in TE buffer and treated with RNase I. An equivalent amount 
of materials from 106 cells was loaded and electrophoresed on a 
1.5%  agarose gel.  The gel was stained with  1 #g/ml ethidium 
bromide and  photographed  with  Polaroid  type 55  film (Sigma 
Chemical Co.) using a UV transiUuminator and an MP-3 Polaroid 
camera setup. 
Mice.  Specific pathogen-free female C3H/HeN mice and male 
athymic BALB/c nude mice were purchased from the Animal Pro- 
tection Area of the National Cancer Institute Frederick  Cancer Re- 
search  Facility (Frederick,  MD).  The mice were maintained  in 
laminar air-flow cabinets under specific pathogen-free conditions 
in facilities approved by the American Association for Accredita- 
tion of Laboratory Animal Care and in accordance with current 
regulations  and  standards  of the  United  States  Department  of 
Agriculture, Department of Health and Human Services, and Na- 
tional Institutes of Health. The mice were used between the ages 
of 8 and  12 wk. 
Tumorigenicity and Experimental Metastasis.  To produce tumors, 
2  x  10  s cells suspended in 0.1 ml HBSS were injected subcutane- 
ously into the flank region of nude mice (n  =  5). Tumor take and 
size were monitored three times per week. Tumor mass exceeding 
3 mm in diameter was recorded as a positive take. 
To produce experimental lung metastasis,  unanesthetized C3H/ 
HeN mice were injected with viable tumor cells suspended in 0.2 ml 
1335  Xie et al. HBSS into the lateral tail vein. The mice were killed 6 wk later 
and the lungs were removed, washed, and fixed  in Bouin's solution 
to differentiate  the neoplastic lesions from the organ parenchyma. 
The lung nodules were counted with the aid of a dissecting mi- 
croscope. 
In  Vitro Labeling of Cells with ['2sI]IdUrd.  Tumor cells were 
seeded into 150-cm  2 tissue culture flasks at 4  x  106 calls/flask  in 
MEM-NMA. 24 h later, 0.3 #Ci/ml [12sI]IdUrd was added. 24 h 
after that, the cell monohyers were rinsed twice with excess Ca  2+- 
and Mg2+-free HBSS to remove nonbound radioiodine (3). Cell 
monolayers  were then overlaid  with a thin layer of 0.25% trypsin- 
0.02% EDTA solution for 1 min. The cells were dislodged from 
the plastic and suspended in medium. The call suspension was 
washed and resuspended in Ca  2+- and Mg2+-free HBSS at a final 
concentration of 10  s cells per 0.2 ml, the inoculum volume per 
mouse. 
Distribution and Fate of  F2sI]IdUrd-labeled  Cells after Intravenous  In- 
jection.  Labded ceils were injected intravenously into unanesthe- 
tized mice, and groups of five mice were killed at intervals there- 
after. Lung, liver,  kidneys, and spleen  of  each mouse were collected 
and placed in test tubes containing 70% ethanol In addition, 0.2 
ml of blood from each mouse was collected and placed in a test 
tube for direct measurement of radioactivity. The ethanol was 
replaced daily for 3 d to remove all soluble 12sI released from dead 
cells (3). The radioactivity in all of the organ samples was deter- 
mined using a gamma counter (Gamma-Trac  model 1185; TM Ana- 
lytic, Elk Grove, IL). Triplicate input tubes (containing 0.2 ml of 
inoculum) were retained, and the radioactivity was counted at the 
same time as the sample organs. The mean counts in organs from 
each group of five animals per time point were expressed as the 
percentage of input counts. Measurements were corrected for ra- 
dioactivity decay in input cells. 
We also monitored the survival and fate of [nsI]IdUrd-labeled 
cells in mice injected intraperitoneally  twice daily  with 20 rag/dose 
NMA dissolved in HBSS. The treatment dose and schedule pro- 
duced 70% inhibition in levels of nitrate induced in C3H/HeN 
mice by injection of 50 #g LPS. NMA was administered 1 d before 
and 3 d after the intravenous injection of radiolabeled cells. Cell 
survival in vivo was determined as described above. 
Statistical Analysis.  The in vitro data were analyzed for sig- 
nificance by the Student's t test (two-tailed), and the in vivo data 
were analyzed by the Mann-Whitney U  test. 
Results 
Transfection and Selection of iNOS-expressing  Cells.  To es- 
tablish stable transfectants, the K-1735 C4 parental cells (C4.P) 
were cotransfected with pcDNAI/Neo and either piNOS-L8 
(active iNOS) or piNOS-S2 (inactive iNOS) genes (29, 32). 
Cells transfected with only pcDNAI/Neo served as a vector 
control. The MEM was free of  t-arginine and contained 3 mM 
of NMA. Endogenous iNOS DNA was found in C4.P cells 
growing  in  MEM  and  in  C4.P  cells  and  C4.Neo.3  cells 
growing in MEM-NMA. Both recombinant and endogenous 
iNOS DNA was found in C4.$2.3 and C4.L8.5 cells growing 
in MEM-NMA (data not shown). Gene expression for iNOS 
was analyzed by Northern blot (Fig. 1) showing highly specific 
iNOS mRNA transcripts in C4.$2.3 and C4.L8.5. iNOS- 
positive clones were further characterized by immunocyto- 
chemistry using specific anti-iNOS mAb;  homogeneously 
staining clones were identified for in vivo analysis (Fig.  2). 
The functional activity ofiNOS was measured by an enzymatic 
Figure  1.  Northern  blot anal- 
yses  for iNOS expression,  mRNA 
was  isolated from C4.P cells 
growing in  MEM  (lane 1)  or 
MEM-NMA (lane 2), C4.Neo.3 
(lane 3),  C4.$2.3 (lane 4),  or 
C4.L8.5 (lane  5) cells. Samples  (2 
/~g) were  separated  on 1% agarose 
gel, transferred to  GeneScreen 
membrane,  and  probed with 
[32p] iNOS cDNA. Note high 
mRNA expression in  C4.$2.3 
(lane 4) and C4.L8.5 (lane  5) cells. 
This is a representative  experiment 
of three. 
activity assay. Only the protein preparations from the C4.L8.5 
cells had significant enzymatic activity (Fig.  3; P  <0.001). 
These data confirm the introduction into and expression  of 
iNOS genes  in K-1735  C4 cells. 
Tumorigenicity.  Tumor cells were injected subcutaneously 
into groups of nude mice. C4.P, C4.Neo.3, and C4.$2.3 cells 
produced rapidly growing tumors. By day 21 after injection, 
no tumors (a mass >3 mm in diameter) were produced by 
C4.L8.5 cells (data not shown). 
Production of Metastasis by Cells Transfected with Functional 
iNOS Gene.  In the next set of experiments, C3H/HeN mice 
were injected intravenously with 50,000  viable  K-1735  C4 
parental (C4.P) and several Neo-transfected clones. The me- 
dian number of lung metastases produced by these cells was 
less than that of parental cells (Table 1). The C4.Neo.3 clone 
produced an average number of metastases  and was chosen 
for all further studies. The incubation of C4 cells in MEM- 
NMA did not affect their metastatic potential. C4 cells in- 
cubated in MEM alone or MEM-NMA produced a median 
number of 56 and 45 lung metastases,  respectively  (data not 
shown). For all experiments, we therefore used cells cultured 
in MEM-NMA. In the next set of experiments, C3H/HeN 
mice were injected intravenously with 100,000 viable C4.P 
ceils and several piNOS-S2 (inactive)  or piNOS-L8 (active) 
transfected clones (Table 1). By day 21 after injection, C4.P 
cells produced a median of >200 lung metastases.  C4.$2.3, 
C4.$2.4, and C4.$2.6 cells produced a median of 94, 72, and 
112 lung metastases, respectively.  C4.$2.3 calls were chosen 
for further studies. Mice injected with C4.L8 cells were killed 
on day 45 after i.v. injection. Even then, C4.L8.5, C4.L8.11, 
and C4.L8.13 cells were not metastatic. Only a single metastasis 
in a  single  mouse was  found (Table  1).  The  single lung 
metastasis was isolated and a line established in culture. These 
cells did not produce NO (in the absence of NMA), and the 
loss of iNOS gene expression  was confirmed by a negative 
Northern blot analysis (data not shown). C4.L8.5 cells were 
chosen for further studies. 
To rule out that the abrogation of metastatic potential by 
C4.L8 ceils  was due to  immune rejection (1,  13-15),  we 
repeated the studies  in athymic nude mice (Table 2). C4.P, 
C4.Neo.3, C4.$2.3, and C4.L8.5 cells were injected intrave- 
nously into nude mice at the inoculum of 100,000  (Expt. 
1) and 125,000  (Expt. 2) viable cells. The mice were killed 
after 28 d. C4.P, C4.Neo.3, and C4.$2.3 cells were all highly 
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tein. Cells  were seeded  into chamber  slides,  incubated 
for 4-6 h, and then  fixed  and stained  with either  anti- 
iNOS mAb or control  IgG. Note positive  reaction  in 
cells transfected  with piNOS-S2 or piNOS-L8 gene. 
The reactivity  in the C4.L8.5  cells  is more  intense  and 
uniform. 
metastatic. In contrast, C4.L8.5 cells were not metastatic. 
(Only a single metastasis in a single mouse was found). 
Distribution and Fate of  p2sI]IdUrd-labeled Tumor Cells.  The 
organ  distribution  and  fate  of  [12sI]IdUrd-labeled  C4.P, 
C4.Neo.3, C4.$2.3, and C4.L8.5 cells were followed for from 
10 rain to 72 h after i.v. injection (Fig. 4 A). The only organ 
in which significant proportions of labeled cells were detected 
was the lung. At 10 min and 24 h after injection, there were 
no discernible differences among the lines in the percentage 
of input  cells  remaining in the lungs.  By 72  h,  however, 
significant differences  had emerged in the number of cells 
surviving in the lungs, making it possible to separate the lines. 
The percentage of viable C4.P, C4.Neo.3, and C4.$2.3 cells 
surviving in the lungs was 4, 4, and 2%, respectively. In con- 
trast, the percentage of C4.L8.5 cells surviving in the lung 
was <0.2%.  These data clearly agreed with a previous re- 
port on survival of metastatic and nonmetastatic K-1735 clones 
in lungs of syngeneic mice (28,  44). 
In the next set of experiments, we injected [12sI]IdUrd- 
labeled C4.P, C4.Neo.3, C4.$2.3, and C4.L8.5 cells intrave- 
nously into normal mice or mice injected intraperitoneally 
with 20 mg NMA twice a day for 4 d (1 d before and 3 d 
after tumor injection). The percentage of surviving cells in 
the lungs of mice was determined on day 3 after i.v. injection 
(Fig. 4 B). Regardless  of the tumor cells injected, enhanced 
survival of tumor cells was found in the lungs of mice treated 
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Figure 3.  iNOS  enzymatic  activity.  Cells  were  cultured  in MEM-NMA 
to semiconfluence,  at which point protein  was extracted  and NOS activity 
was measured  and expressed  as nmole  of (nitrite/nitrate)/mg  protein. The 
values are mean + SD of triplicate cultures. This is one representative 
experiment of three. 
with NMA, suggesting that one major factor that contributes 
to the death and clearing of tumor cells from the lung (28) 
is the production of NO. 
Expression of Recombinant  iNOS and Apoptosis.  Previous 
studies from our laboratory demonstrated that synthesis of 
recombinant NO induces apoptosis in murine-transformed 
fibroblasts (27). We next determined whether expression of 
Table  2.  Abrogation of Metastatic Potential in K-1735  C4 
Cells Transfected with the iNOS Gene and Injected into Nude 
Mice 
Lung metastasis 
Cell line*  Incidence  Median  Range 
Expt.  1 
C4.P  10/10  174  114->200 
C4.Neo.3  10/10  146  77->200 
C4.$2.3  10/10  110  41-184 
C4.L8.5  0/10  0*  All 0 
Expt. 2 
C4.P  10/10  >200  All >200 
C4.Neo.3  10/10  >200  All >200 
C4.$2.3  6/6  180  102->200 
C4.L8.5  1/10  0*  0-1 
* BALB/c nude mice were injected intravenously  with 100,000 viable 
cells (Expt. 1) or 125,000 viable cells (Expt. 2) and killed 28 d later. 
The number of experimental  lung metastases was determined  using a dis- 
secting microscope. 
*  p <0.001, Mann-Whimey test. 
Table  1.  Experimental Lung Metastasis Produced by K-1735 
C4 Cells Transfected with the iNOS Gene 
Lung metastasis 
Cell line*  Incidence  Median  Range 
Expt.  1 
C4.P  5/5  50  21-70 
C4.Neo. 1  5/5  28  12-35 
C4.Neo.2  5/5  39  31-56 
C4.Neo.3  5/5  33  23-50 
C4.Ne0.4  5/5  27  16-31 
C4.Neo.5  5/5  48  43-68 
Expt. 2 
C4.P  10/10  >200  All >200 
C4.$2.3  10/10  94  34-123 
C4.$2.4  10/10  72  39-156 
C4.$2.6  10/10  112  51-182 
C4.L8.5  0/10  0*  All 0 
C4.L8.11  1/10  0*  0-1 
C4.L8.13  0/10  0*  All 0 
* Syngeneic mice were injected  intravenously  with 50,000 (Expt. 1) and 
100,000 (Expt. 2) viable tumor cells and killed after 21 or 45 d (C4.L8) 
when the number of experimental  lung metastases was determined  using 
a dissecting microscope. 
*p <0.001, Mann-Whitney test. 
recombinant iNOS in the K-1735 C4 cells was associated with 
apoptosis. The cells were cultured in MEM or MEM-NMA. 
Nitrite accumulation was only detected in the cultures of 
C4.L8.5 cells growing in MEM (Fig. 5 A). The peak level 
of nitrite was reached by 48 h of incubation in MEM (Fig. 
5 B). In parallel studies,  we determined whether the expres- 
sion of recombinant iNOS correlates with inhibition of cell 
growth or cell lysis. Tumor cells were cultured in MEM or 
MEM-NMA.  Significant cytostasis (Fig.  6 A) and cytolysis 
(Fig. 6 B) were found only in C4.L8.5 cells cultured in MEM. 
The inhibition  of NO  by  NMA  prevented death  of the 
C4.L8.5 cells. 
The death of the C4.L8.5 cells (cultured in MEM) was 
associated with genomic DNA damage. The data shown in 
Fig. 7 A reveal that by 48 h, significant DNA fragmentation 
occurred in C4.L8.5 cells incubated in medium without NMA. 
This DNA fragmentation could be inhibited by 3 mM NMA. 
To characterize the genomic DNA damage, we electropho- 
resed genomic DNA fragments (Fig. 7 B, lanes 1-6) and the 
corresponding intact chromatin DNA (Fig. 7 B, lanes 7-12) 
from the various cultures (after 48 h incubation) on a 1.5% 
agarose gel. DNA laddering of C4.L8.5 cells was found (lane 
5),  indicating that cell death occurred by apoptosis. 
Discussion 
The process of metastasis consists of multiple sequential 
steps that include motility, invasion, survival in the circula- 
tion,  adhesion,  extravasation,  and  growth  (1-4).  During 
metastasis,  tumor cells are subjected to such extreme selec- 
tion pressures that the majority of tumor cells that enter the 
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Figure  4.  Arrest and survival of [125I]IdUrd-labeled  tumor cells in the 
lungs of syngeneic mice. (.4) Radiolabeled cells (10  s) were injected intra- 
venously into mice. At the indicated time points, groups of mice (n  = 
5) were killed and visceral organs were removed and processed as described 
in Materials and Methods. Percent surviving cells in the lungs was calcu- 
lated by comparison to initial inoculum. This is one representative experi- 
ment of two.  *p <0.01  Mann-Whitney  U  test.  (B) Mice were injected 
intraperitoneally with either HBSS or 20 mg NMA twice daily for 4 d. 
Radiolabeled tumor cells were injected intravenously after 1 d  of treat- 
ment and the mice were killed on day 3 after tumor cell injection. The 
enhanced survival of tumor cells in NMA-treated mice was significant. 
*p <0.01. 
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Figure  5.  NO production by K-1735 C4 cells. (A) Cells (1.5-2  x  106) 
were plated into 30-mm dishes in triplicate in MEM or MEM-NMA. After 
48 h,  the amount of nitrite in the culture supernatants  was determined 
as described in Materials and Methods. This is one representative experi- 
ment of five. *p <0.001.  (B) Kinetics of NO production by C4.L8.5 cells. 
C4.L8.5 cells (1.5-2  x  106) were plated into 30-mm dishes in triplicate 
in MEM or MEM-NMA.  After 12, 24, 36,  48, and 72 h,  the amount 
of nitrite in the culture supematants was determined as described in Materials 
and Methods. The differences  in nitrite were significant (p <0.001). This 
is one representative experiment of five. 
circulation rapidly die (7-11). This selection pressure may ex- 
plain the finding that metastases are clonal in origin (45) and 
can develop from single progenitor cells (31). Neoplasms ex- 
hibit heterogeneity for invasion and metastasis (1, 4), which 
is expressed in differences in survival between nonmetastatic 
cells and metastatic cells (46). Studies using the well-charac- 
terized murine K-1735 melanoma system of clones, cell lines, 
and somatic cell hybrids (betwecaa  nonmetastatic and metastatic 
cells) concluded that nonmetastatic cells exhibited high levels 
of iNOS, whereas metastatic cells did not (28). The in vitro 
treatment of tumor cells with cytokines,  such as TNF-a, 
IL-1, and IFN-% induced production of NO and then apop- 
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tosis and both sequela could be blocked by NMA (28). These 
data suggest that one factor contributing to the death of cir- 
culating tumor cells is the production of NO, but its causal 
relationship  to metastasis remained unclear. 
The present results demonstrate that the transfection of 
highly metastatic K-1735 C4 cells (which express low levels 
of iNOS) with an enzymaticaUy  active iNOS expression  vector 
renders the cells nonmetastatic by inducing high levels of  NO 
production.  In the presence of NMA, the cells' proliferation 
in vitro and survival in vivo was very similar to that of pa- 
rental cells transfected with a control vector (neomycin resis- 
tance) or cells transfected with inactive iNOS cDNA. The A 
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Figure 6.  In vitro survival of K-1735 C4 cells transfected with the iNOS 
gene.  (A) In vitro cytostasis assay. Cells were plated into culture dishes 
in MEM or MEM-NMA. After 72 h, the number of viable cells in tripli- 
cate cultures was determined by the MTT assay as described in Materials 
and Methods.  The difference in proliferation  between C4.L8.5  cells incu- 
bated in the presence or absence of NMA was highly significant (p <0.001). 
This is one representative experiment  of three. (B) In vitro cytolysis assay. 
Tumor cells prelabeled with [3H]thymidine were plated into culture dishes 
in MEM or MEM-NMA. After 48 h,  triplicate  cultures  were washed, 
the adherent cells lysed, and radioactivity monitored as described in Materials 
and Methods.  The difference in survival between C4.L8.5  cells incubated 
in the presence or absence of NMA was highly significant  (p <0.001). 
This is one representative  experiment of three. 
Figure  7.  Internucleosomal  DNA fragmentation.  (A) [3H]thymidine- 
labeled tumor cells (1.5-2  x  106) were plated into 30-ram dishes in MEM 
or MEM-NMA. After different times, fragmented  and intact  chromatin 
DNA samples were collected from triplicate cultures. After different incuba- 
tion periods, the percentage of fragmented  DNA was determined  as de- 
scribed in Materials and Methods. This is one representative experiment  of 
two. (B) Induction of internucleosomal DNA fragmentation in K-1735 C4 
cells￿9  Cells were incubated in MEM or MEM-NMA for 48 h when frag- 
mented and  intact chromatin  DNA from  106 cells was  collected.  The 
DNA was  treated  with proteinase  K, extracted,  precipitated,  pelleted, 
and dissolved in TE buffer and then treated with gNase I. An equivalent 
amount of material was loaded on a 1.5%  agarose gel, electrophoresed, 
stained,  and photographed  (lanes 1-6,  fragmented  DNA, and  lanes 7- 
12, chromatin DNA). Lanes 1 and  7, C4.Neo.3,  MEM; lanes 2 and 8, 
C4.Neo.3, MEM-NMA; lanes 3 and 9, C4.$2.3,  MEM; lanes 4 and 10, 
C4.$2.3,  MEM-NMA; lanes 5 and 11, C4.L8.5,  MEM; lanes 6 and 12, 
C4.L8.5,  MEM-NMA. This is a representative  experiment  of three. 
growth (tumorigenicity) of the active iNOS cDNA trans- 
fected cells was inhibited and production of metastasis was 
abrogated, providing direct evidence  for the role of  iNOS/NO 
in the prevention  of cancer metastasis. 
The successful transfection of the K-1735 C4 cells with 
the enzymaticaUy active iNOS gene L8 (29, 30, 33) required 
the use of t-arginine-free medium and the continuous pres- 
ence of 3 mM NMA. In medium containing t-arginine and 
devoid of NMA, the transfected C4.L8 cells produced high 
levels of  NO and underwent apoptosis. To examine the growth 
of the various K-1735 C4 cells under in vivo conditions,  we 
injected them into the subcutis of nude mice. All the control 
cells produced rapidly growing tumors, whereas the C4.L8.5 
cells did not. Because the kinetics of subcutaneous growth 
are difficult to assess, we used the cells in a well-established 
experimental  metastasis assay. 
Experimental metastases are tumor colonies produced after 
i.v. injection of cells. Although these tumor cells bypass the 
initial steps of metastasis (separation from primary neoplasm 
and invasion and release into blood vessels or lymphatics), 
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for metastases to be formed. In this  study, we equate ex- 
perimental metastasis with the blood-borne spread of tumor 
cells. The transfection of neo resistance gene or enzymati- 
cally inactive iNOS gene into the highly metastatic K-1735 
C4 cells reduced the number of lung metastases.  In contrast, 
the transfection of enzymatically active iNOS gene into the 
highly metastatic C4 cells abrogated production of lung meta- 
stasis after i.v. injection. 
To rule out that the abrogation of metastasis by C4.L8 
cells was due to immune rejection (1, 13,  15), we repeated 
the experiment using athymic nude mice. Even in the immune- 
deficient mice, C4.L8.5  cells were not metastatic, whereas 
C4.P, C4.Neo.3, and C4.$2.3 cells were still highly metastatic. 
Collectively, these data show that although transfection per 
se can somewhat reduce metastatic potential of K-1735  C4 
cells, only transfection with piNOS-L8 gene renders the cells 
(C4.L8.5,  C4.L8.11,  C4.L8.13)  nonmetastatic. 
To  determine whether the abrogation  of metastasis  by 
C4.L8.5 cells (active iNOS gene) was due to initial cell arrest 
or to later events, we studied the fate of [125I]IdUrd-labeled 
tumor cells in normal and NMA-treated mice. The initial 
arrest and survival of [12sI]IdUrd-labeled  K-1735  C4 cells 
(transfected with enzyrnatically active iNOS gene) in the lungs 
of syngeneic mice was very similar to that of all control cells. 
Within 24-72 h however, only 0.1% of the iNOS-transfected 
cells survived, whereas ~>2% of control cells survived. The 
low survival rate of C4.L8.5  cells was very similar to that 
found for nonmetastatic clones of K-1735  (28). 
The death of K-1735 C4.L8.5 cells could have been due 
to factors unrelated to transfection with the enzymatically 
active iNOS gene. To examine this possibility, we studied 
the  fate  and  survival  of [12sI]IdUrd-labeled  cells  in  mice 
treated twice daily with i.p.  injections of 20 mg NMA (a 
dose suf~cient to inhibit 70% of production in mice injected 
with 50/zg LPS). Enhanced survival of all K-1735 cells was 
found in NMA-treated mice with significant increase in sur- 
vival for C4.L8.5 cells. These in vivo data confirm that NO 
is a major factor that contributes to the death of circulating 
tumor cells. Since lung metastases produced by K-1735 mela- 
noma cells can originate from single surviving cells (31, 44), 
the survival of cells in the lung at 72 h after injection predicts 
the development of visible metastases (4,  46). 
The production of NO by tumor cells may reduce their 
capacity to produce metastasis by at least two nonmutually 
exclusive mechanisms. The aggregation of platelets around 
tumor cells enhanced arrest in capillary beds (10, 11) and NO 
has been shown to inhibit platelet aggregation (25, 26, 47). 
More likely, however, the production of NO can induce cell 
death in normal, transformed, and tumorigenic cells by an 
apoptotic process (27). The K-1735 C4 cells transfected with 
the enzymatically active iNOS gene (C4.L8.5) but not the 
enzymatically inactive iNOS gene (C4.$2.3) or the Neo re- 
sistance  gene (C4.Neo.3)  produced high levels of NO fol- 
lowed by genomic DNA damage and cell death, as moni- 
tored by both cytostasis and cytolysis analyses.  These data 
provide direct evidence that NO can induce DNA fragmen- 
tation and apoptosis and suggest the usefulness of this cell 
system to study apoptosis. 
In summary, the introduction of an enzymatically active 
iNOS  gene into highly metastatic murine melanoma cells 
induces apoptosis, suppresses growth, and abrogates metastasis. 
These data provide direct evidence that expression of iNOS 
and production of NO can induce apoptosis and is respon- 
sible for inhibiting the malignant potential of tumor cells. 
The use of the iNOS gene for treatment of malignant mela- 
noma metastases is now under investigation. 
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